Bio-Matrix Scientific Group Inc. Update on Class 10,000 Stem Cell Banking and Cellular Tissue Processing Laboratories.SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BMSN BMSN Seaman, Boatswain's Mate Striker (Naval Rating) ), a biotechnology company focused on stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. cryogenics cryogenics: see low-temperature physics. cryogenics Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties. and disposable stem cell / tissue transfer instruments, announced today an update on the construction and installation of its new Stem Cell Class 10,000 Processing Laboratory. As a follow-up to the state of the facility press release issued last week, a Company spokesperson offered the following timeline to facility completion: October 16th - Laboratory and Air controls to be installed. October 17th - Calibration and Systems Testing of all controls to take place. October 18th& 19th - City inspectors to conduct final review of construction and installation of class 10,000 processing laboratory. October 23rd - Bio-Matrix anticipates starting the facility accreditation process. Brian Pockett, Managing Director and COO, stated, "The new class 10,000 laboratory will now enter into the essential process towards full American Association of Tissue Banks accreditation." Bio-Matrix' new 15,000 sq ft state-of-the-art facility, located in the heart of the San Diego biotechnology corridor, will house Bio-Matrix' secure Cryogenic Stem Cell Bank, 3 Research laboratories, aseptic aseptic /asep·tic/ (-tik) free from infection or septic material. a·sep·tic adj. Of, relating to, or characterized by asepsis. cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry flow cytometry (flōˑ sī·t  ˑ·m laboratories. This press release is available on the company's official online Investor Relations Investor relations The process by which the corporation communicates with its investors. HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time. About Bio-Matrix Scientific Group Inc. Bio-Matrix Scientific Group Inc. (www.BMXGonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The Company aligns itself with strategic partners that offer key technologies in biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry. DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion